Kidneys are a major organ for blood filtration and waste elimination and thus play a key role
in the transport and clearance of nanoparticles in vivo. The interactions of nanoparticles with …

Conspectus Nanomedicine has benefited from recent advances in chemistry and biomedical
engineering to produce nanoscale materials as theranostic agents. Well-designed …

Kidney-targeted nanoparticles have become of recent interest due to their potential to
deliver drugs directly to diseased tissue, decrease off-target adverse effects, and increase …

Inorganic nanoparticle (NP) based imaging contrast agents with tuneable shape, size, and
surface chemistry have immense potential in both basic research and clinical settings …

Nanomedicines have been the subject of great interest for the treatment, diagnosis, and
research of disease; however, few specifically address kidney disorders. Nanotechnology …

Abstract Treatment and management of kidney disease currently presents an enormous
global burden, and the application of nanotechnology principles to renal disease therapy …

In recent years, several publications reported that nanoparticles larger than the kidney
filtration threshold were found intact in the urine after being injected into laboratory mice …

While biodistribution of nanoparticles (NPs) has been widely studied at the organ level,
relatively little is known about their disposition in organs at the cellular level, especially after …

Nanoparticles possess enormous potential as diagnostic imaging agents and hold promise
for the development of multimodality agents with both imaging and therapeutic capabilities …

Nanoparticles are an enabling technology for the creation of tissue-/cell-specific
therapeutics that have been investigated extensively as targeted therapeutics for cancer …